Numis Securities Upgrades Scapa Group (LON:SCPA) to “Add”

Numis Securities upgraded shares of Scapa Group (LON:SCPA) to an add rating in a research note published on Tuesday, December 19th. The brokerage currently has GBX 485 ($6.58) target price on the stock.

Several other research analysts have also issued reports on SCPA. N+1 Singer raised shares of Scapa Group to a buy rating and set a GBX 490 ($6.64) target price on the stock in a research note on Thursday, October 5th. Berenberg Bank reaffirmed a buy rating and issued a GBX 500 ($6.78) target price on shares of Scapa Group in a research note on Friday, October 6th.

Shares of Scapa Group (LON SCPA) traded up GBX 5.18 ($0.07) during trading hours on Tuesday, reaching GBX 458.18 ($6.21). 129,444 shares of the company’s stock were exchanged, compared to its average volume of 207,312. Scapa Group has a 12-month low of GBX 317 ($4.30) and a 12-month high of GBX 522.39 ($7.08). The company has a market cap of $703.77 and a price-to-earnings ratio of 3,272.71.

Scapa Group (LON:SCPA) last issued its quarterly earnings data on Tuesday, November 21st. The company reported GBX 8.30 ($0.11) EPS for the quarter. Scapa Group had a net margin of 7.90% and a return on equity of 21.69%. The firm had revenue of £145.60 million for the quarter.

In other Scapa Group news, insider Graham Hardcastle bought 15,000 shares of Scapa Group stock in a transaction dated Monday, November 27th. The shares were bought at an average price of GBX 482 ($6.54) per share, with a total value of £72,300 ($98,047.19).

TRADEMARK VIOLATION NOTICE: “Numis Securities Upgrades Scapa Group (LON:SCPA) to “Add”” was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this article on another publication, it was illegally copied and reposted in violation of US & international copyright laws. The original version of this article can be viewed at

About Scapa Group

Scapa Group plc is a United Kingdom-based global supplier of bonding solutions and manufacturer of adhesive-based products for the Healthcare and Industrial markets. The Company has a global footprint, with production sites in Asia, Europe and the United States. The Company conducts the activities through two distinct and separate businesses: Healthcare and Industrial business units.

Receive News & Ratings for Scapa Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scapa Group and related companies with's FREE daily email newsletter.

Leave a Reply